SEC Filing | Charles River Laboratories International, Inc.

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Parisotto Shannon M

(Last)

(First)

(Middle)

251 BALLARDVALE STREET

(Street)

WILMINGTON

01887

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/24/2022

3. Issuer Name and Ticker or Trading Symbol
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. [ CRL ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
CEVP, Disc & Safety Assessment

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	2,499⁽¹⁾	D
Common Stock	29,036	I	by Karpathos Investments LLC

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options (Right to Buy)	02/23/2019⁽²⁾	02/23/2023	Common Stock	6,837	109.34	D
Stock Options (Right to Buy)	02/22/2020⁽³⁾	02/22/2024	Common Stock	5,882	144.67	D
Stock Options (Right to Buy)	05/29/2021⁽⁴⁾	05/29/2030	Common Stock	3,714	179.66	D
Stock Options (Right to Buy)	05/28/2022⁽⁵⁾	05/28/2031	Common Stock	2,195	337.99	D
Stock Options (Right to Buy)	05/27/2023⁽⁶⁾	05/27/2032	Common Stock	2,875	244.41	D

Explanation of Responses:

1. Consists of: (a) 345 unvested restricted stock units (RSUs) which vest on 2/22/2023 (b) 557 unvested restricted stock units (RSUs) which vest as follows: 278 on 5/29/2023, and 279 on 5/29/2024. (c) 533 unvested restricted stock units (RSUs) which vest as follows: 178 on 5/28/2023, 177 on 5/28/2024, and 178 on 5/28/2025. (d) 1,064 unvested restricted stock units (RSUs) which vest as follows: 266 on 5/27/2023, 266 on 5/27/2024, 266 on 5/27/2025, and 266 on 5/27/2026. Each RSU represents a contingent right to receive one share of common stock.

2. Stock Options fully vested.

3. 4,411 Stock Options are vested and the remaining Stock Options will vest as follows: 1,471 on 2/22/2023.

4. 1,857 Stock Options are vested and the remaining Stock Options will vest as follows: 928 on 5/29/2023 and 929 on 5/29/2024.

5. 548 Stock Options are vested and the remaining Stock Options will vest as follows: 549 on 5/28/2023, 549 on 5/28/2024 and 549 on 5/28/2025.

6. Stock Options will vest as follows: 718 on 5/27/2023, 719 on 5/27/2024, 719 on 5/27/2025 and 719 on 5/27/2026.

	/s/ Shannon M. Parisotto	11/01/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.